IDENTIFICATION OF OPTIMAL SUBCUTANEOUS DOSES OF TOCILIZUMAB IN CHILDREN WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS

被引：0

作者：

Jafri, Shazad ^{[1
]}

Ramanan, Athimalaipet V. ^{[2
]}

De Benedetti, Fabrizio ^{[3
]}

Ruperto, Nicolino ^{[4
]}

Lovell, Daniel ^{[5
]}

Cuttica, Ruben ^{[6
]}

Weiss, Jennifer E. ^{[7
]}

Henrickson, Michael ^{[4
]}

Schmeling, Heinrike ^{[8
]}

Anton, Jordi ^{[9
]}

Minden, Kirsten ^{[10
]}

Hsu, Joy ^{[11
]}

Bharucha, Kamal ^{[11
]}

Wimalasundera, Sunethra ^{[13
]}

Kadva, Alysha K. ^{[12
]}

Upmanyu, Ruchi ^{[13
]}

Mallalieu, Navita L. ^{[11
]}

Martini, Alberto ^{[3
]}

Brunner, Hermine ^{[4
]}

机构：

[1] Chugai Pharma UK, London, England

[2] Bristol Royal Hosp Children, Dept Paediat Rheumatol, Bristol, Avon, England

[3] IRCCS, Osped Pediatr Bambino Gesu`, Lab Rheumatol, Rome, Italy

[4] PRINTO Coordinating Ctr, Ist Giannina Gaslini Pediat Reumatol 2, Genoa, Italy

[5] Hosp Med Ctr, Cincinnati Childrens, PRCSG, Cincinnati, OH USA

[6] Hosp Gen Ninos Pedro De Elizalde, Dept Paediat Rheumatol, Buenos Aires, DF, Argentina

[7] Hackensack Univ, Med Ctr, Pediat Rheumatol, Hackensack, NJ USA

[8] Univ Calgary, Alberta Childrens Hosp, Dept Pediat, Calgary, AB, Canada

[9] Hosp San Juan Dios, Paediat Rheumatol Unit, Barcelona, Spain

[10] Charite Univ Med Berlin, Berlin, Germany

[11] Roche Innovat Ctr, New York, NY USA

[12] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA

[13] Roche, Welwyn Garden City, Herts, England

来源：

RHEUMATOLOGY | 2017年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4 / 4

页数：1

共 50 条

[1] Identification of Optimal Subcutaneous Doses of Tocilizumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis
Brunner, Hermine
Ruperto, Nicola
Martini, Alberto
Ramanan, Athimalaipet
Cuttica, Ruben
Weiss, Jennifer E.
Henrickson, Michael
Schmeling, Heinrike
Anton, Jordi
Minden, Kirsten
Hsu, Joy
Bharucha, Kamal
Wimalasundera, Sunethra
Kadva, Alysha K.
Upmanyu, Ruchi
Mallalieu, Navita L.
Lovell, Daniel
De Benedetti, Fabrizio
ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 59 - 60
[2] Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis
Brunner, Hermine I.
Ruperto, Nicola
Martini, Alberto
Ramanan, Athimalaipet V.
Cuttica, Ruben
Weiss, Jennifer E.
Henrickson, Michael
Schmeling, Heinrike
Anton, Jordi
Minden, Kirsten
Hsu, Joy
Bharucha, Kamal
Wimalasundera, Sunethra
Kadva, Alysha K.
Upmanyu, Ruchi
Mallalieu, Navita L.
Douglass, Wendy
Lovell, Daniel J.
De Benedetti, Fabrizio
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[3] IDENTIFICATION OF OPTIMAL SUBCUTANEOUS (SC) DOSES OF TOCILIZUMAB IN CHILDREN WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS (PCJIA)
De Benedetti, F.
Ruperto, N.
Lovell, D.
Ramanan, A. V.
Cuttica, R.
Weiss, J. E.
Henrickson, M.
Schmeling, H.
Anton, J.
Minden, K.
Hsu, J.
Bharucha, K.
Wimalasundera, S.
Kadva, A. K.
Upmanyu, R.
Mallalieu, N. L.
Martini, A.
Brunner, H.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 396 - 396
[4] Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Systemic Juvenile Idiopathic Arthritis
Brunner, Hermine I.
Ruperto, Nicola
Lovell, Daniel J.
Horneff, Gerd
Gamir-Gamir, Maria Luz
Hufnagel, Markus
Hsu, Joy
Bao, Min
Douglass, Wendy
Mallalieu, Navita L.
Wells, Chris
Mala, Christopher M.
De Benedetti, Fabrizio
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[5] IDENTIFICATION OF OPTIMAL SUBCUTANEOUS DOSES OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Brunner, H.
Ruperto, N.
Lovell, D.
Calvo-Penedes, I.
Horneff, G.
Gamir Gamir, M. L.
Hufnagel, M.
Hsu, J.
Bao, M.
Douglass, W.
Mallalieu, N. L.
Wells, C.
Mela, C. M.
De Benedetti, F.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 102 - 102
[6] Clinical pharmacology of tocilizumab for the treatment of polyarticular-course juvenile idiopathic arthritis
Zhang, Xiaoping
Chen, Ya-Chi
Terao, Kimio
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (05) : 471 - 482
[7] GROWTH AND DEVELOPMENT OF PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH SUBCUTANEOUS ABATACEPT
Ruperto, Nicolino
Brunner, Hermine
Cornejo, Gabriel Vega
Berman, Alberto
Anton, Jordi
Cuttica, Ruben
Keltsev, Vladimir
Viola, Diego Oscar
Lauwerys, Bernard
Rama, Maria Elena
Bohnsack, John
Caillaud, Caroline
Minden, Kirsten
Ally, Mahmood Moosa
Gervais, Elisabeth
Van Zyl, Riana
Gandhi, Yash
Murthy, Bindu
Nys, Marleen
Wong, Robert
Hoang, Jade
Martini, Alberto
Lovell, Daniel J.
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1347 - 1348
[8] PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF TOCILIZUMAB (TCZ) IN POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS (pcJIA)
Zhang, X.
Hsu, J.
Brunner, H.
De Benedetti, F.
Le Gallo, C.
Zuber, Z.
Cuttica, R.
Keltsev, V.
Xavier, R.
Penedes, I. Calvo
Rubio-Perez, N.
Chasnyk, V.
Horneff, G.
Opoka-Winiarska, V.
Quartier, P.
Silva, C.
Spindler, A.
Baildam, E.
Gamir, M. L.
Martin, A.
Siri, D. A.
Smolewska, E.
Lovell, D.
Ruperto, N.
Martini, A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S88 - S89
[9] Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis
Brunner, Hermine, I
Wong, Robert
Nys, Marleen
Kou, Tzuyung D.
Dominique, Alyssa
Martini, Alberto
Lovell, Daniel J.
Ruperto, Nicolino
PEDIATRIC DRUGS, 2020, 22 (06) : 653 - 672
[10] Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis
Geikowski, Tilman
Becker, Ingrid
Horneff, Gerd
RHEUMATOLOGY, 2014, 53 (07) : 1245 - 1249

← 1 2 3 4 5 →